miR-34a sets the "sweet spot" for notch in colorectal cancer stem cells

Douglas J Winton1

  • 1Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK. doug.winton@cruk.cam.ac.uk

Cell Stem Cell
|May 7, 2013
PubMed

Insights

MicroRNA-34a (miR-34a) functions as a critical regulator in colon cancer stem cells. It acts as a toggle switch, controlling whether these cells divide symmetrically or asymmetrically, impacting tumor development.

Area of Science:

  • Stem cell biology
  • Cancer research
  • Molecular mechanisms

Background:

  • Understanding stem cell fate determination is crucial for cancer research.
  • Alternative modes of stem cell division (symmetric vs. asymmetric) are not fully elucidated.
  • Colon cancer stem cells exhibit distinct self-renewal and differentiation pathways.

Discussion:

  • This study investigates the role of microRNA-34a (miR-34a) in regulating stem cell fate.
  • The research focuses on how miR-34a influences the balance between symmetric and asymmetric cell divisions.
  • The findings highlight miR-34a's function as a molecular switch in colon cancer stem cells.

Key Insights:

  • miR-34a acts as a toggle switch controlling stem cell fate.
  • miR-34a dictates binary symmetric and asymmetric cell division modes.
  • This mechanism is specifically observed in colon cancer stem cells.

Outlook:

  • Further research can explore therapeutic strategies targeting miR-34a.
  • Understanding this switch could lead to novel approaches for cancer treatment.
  • Investigating miR-34a's role in other cancer types may reveal broader implications.

Related Concept Videos

Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...